Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 6449 | 8.5 |
09:34 ET | 2976 | 8.5 |
09:36 ET | 2929 | 8.505 |
09:38 ET | 2780 | 8.54 |
09:39 ET | 300 | 8.5 |
09:41 ET | 6274 | 8.54 |
09:43 ET | 200 | 8.49 |
09:45 ET | 1100 | 8.47 |
09:48 ET | 400 | 8.46 |
09:50 ET | 1100 | 8.47 |
09:52 ET | 2383 | 8.43 |
09:54 ET | 1300 | 8.45 |
09:56 ET | 2994 | 8.43 |
09:57 ET | 450 | 8.43 |
09:59 ET | 2471 | 8.46 |
10:01 ET | 1280 | 8.4585 |
10:03 ET | 1100 | 8.44 |
10:06 ET | 2000 | 8.46 |
10:08 ET | 2582 | 8.42 |
10:10 ET | 2718 | 8.4 |
10:12 ET | 578 | 8.4 |
10:14 ET | 3203 | 8.39 |
10:15 ET | 2936 | 8.41 |
10:17 ET | 14171 | 8.42 |
10:19 ET | 1054 | 8.41 |
10:21 ET | 1750 | 8.435 |
10:24 ET | 1346 | 8.44 |
10:26 ET | 2953 | 8.42 |
10:28 ET | 3571 | 8.42 |
10:30 ET | 1764 | 8.438 |
10:32 ET | 2600 | 8.41 |
10:33 ET | 1300 | 8.42 |
10:35 ET | 2049 | 8.38 |
10:37 ET | 1843 | 8.37 |
10:39 ET | 450 | 8.36 |
10:42 ET | 1600 | 8.36 |
10:44 ET | 2643 | 8.37 |
10:46 ET | 800 | 8.3601 |
10:48 ET | 3132 | 8.375 |
10:50 ET | 2313 | 8.405 |
10:51 ET | 1897 | 8.405 |
10:53 ET | 1925 | 8.4 |
10:55 ET | 800 | 8.4 |
10:57 ET | 2180 | 8.415 |
11:00 ET | 800 | 8.415 |
11:02 ET | 2178 | 8.4 |
11:04 ET | 1700 | 8.395 |
11:06 ET | 600 | 8.38 |
11:08 ET | 1722 | 8.37 |
11:09 ET | 500 | 8.36 |
11:11 ET | 18081 | 8.41 |
11:13 ET | 992 | 8.39 |
11:15 ET | 100 | 8.395 |
11:18 ET | 500 | 8.39 |
11:20 ET | 515 | 8.38 |
11:22 ET | 626 | 8.36 |
11:24 ET | 18336 | 8.35 |
11:26 ET | 6225 | 8.34 |
11:27 ET | 5173 | 8.3271 |
11:29 ET | 1827 | 8.29 |
11:31 ET | 1462 | 8.28 |
11:33 ET | 5001 | 8.265 |
11:36 ET | 4967 | 8.26 |
11:38 ET | 700 | 8.26 |
11:40 ET | 1137 | 8.27 |
11:42 ET | 1700 | 8.27 |
11:44 ET | 800 | 8.265 |
11:45 ET | 645 | 8.265 |
11:47 ET | 20166 | 8.28 |
11:49 ET | 1541 | 8.3 |
11:54 ET | 430 | 8.28 |
11:56 ET | 400 | 8.29 |
11:58 ET | 200 | 8.285 |
12:00 ET | 300 | 8.27 |
12:02 ET | 4421 | 8.3 |
12:03 ET | 1873 | 8.265 |
12:05 ET | 100 | 8.27 |
12:07 ET | 1748 | 8.285 |
12:09 ET | 200 | 8.3 |
12:12 ET | 100 | 8.3 |
12:14 ET | 16451 | 8.3 |
12:16 ET | 3282 | 8.32 |
12:18 ET | 2600 | 8.34 |
12:20 ET | 4036 | 8.32 |
12:21 ET | 10354 | 8.33 |
12:23 ET | 17903 | 8.325 |
12:25 ET | 800 | 8.32 |
12:27 ET | 1382 | 8.32 |
12:30 ET | 200 | 8.32 |
12:32 ET | 6154 | 8.305 |
12:34 ET | 8702 | 8.305 |
12:36 ET | 1614 | 8.3025 |
12:38 ET | 2943 | 8.295 |
12:39 ET | 8514 | 8.33 |
12:41 ET | 1100 | 8.3225 |
12:43 ET | 1543 | 8.3225 |
12:45 ET | 11509 | 8.33 |
12:48 ET | 19103 | 8.35 |
12:50 ET | 4901 | 8.37 |
12:52 ET | 2749 | 8.35 |
12:54 ET | 5704 | 8.36 |
12:56 ET | 3104 | 8.38 |
12:57 ET | 4291 | 8.37 |
12:59 ET | 1081 | 8.36 |
01:01 ET | 2033 | 8.33 |
01:03 ET | 7628 | 8.37 |
01:06 ET | 160 | 8.36 |
01:08 ET | 100 | 8.365 |
01:10 ET | 1288 | 8.32 |
01:12 ET | 3160 | 8.3 |
01:14 ET | 500 | 8.29 |
01:15 ET | 2585 | 8.32 |
01:17 ET | 700 | 8.305 |
01:19 ET | 2002 | 8.31 |
01:21 ET | 400 | 8.32 |
01:26 ET | 1396 | 8.317 |
01:28 ET | 3474 | 8.3676 |
01:32 ET | 100 | 8.37 |
01:33 ET | 101 | 8.37 |
01:35 ET | 800 | 8.37 |
01:37 ET | 400 | 8.36 |
01:39 ET | 100 | 8.36 |
01:42 ET | 300 | 8.35 |
01:44 ET | 600 | 8.35 |
01:46 ET | 831 | 8.35 |
01:48 ET | 400 | 8.34 |
01:50 ET | 1055 | 8.35 |
01:51 ET | 406 | 8.3599 |
01:55 ET | 1152 | 8.355 |
01:57 ET | 400 | 8.355 |
02:00 ET | 4171 | 8.36 |
02:04 ET | 400 | 8.36 |
02:06 ET | 200 | 8.38 |
02:08 ET | 2902 | 8.4 |
02:09 ET | 853 | 8.41 |
02:11 ET | 400 | 8.42 |
02:13 ET | 700 | 8.42 |
02:15 ET | 900 | 8.42 |
02:18 ET | 2500 | 8.44 |
02:20 ET | 500 | 8.45 |
02:22 ET | 2578 | 8.43 |
02:24 ET | 505 | 8.42 |
02:26 ET | 100 | 8.41 |
02:27 ET | 2723 | 8.405 |
02:29 ET | 1800 | 8.405 |
02:31 ET | 706 | 8.4042 |
02:33 ET | 1661 | 8.4 |
02:36 ET | 200 | 8.39 |
02:38 ET | 401 | 8.39 |
02:40 ET | 600 | 8.4 |
02:42 ET | 1700 | 8.4 |
02:44 ET | 3081 | 8.39 |
02:47 ET | 1124 | 8.4 |
02:49 ET | 749 | 8.4 |
02:51 ET | 570 | 8.38 |
02:54 ET | 4122 | 8.365 |
02:56 ET | 569 | 8.36 |
02:58 ET | 1284 | 8.36 |
03:00 ET | 575 | 8.365 |
03:02 ET | 2003 | 8.37 |
03:03 ET | 543 | 8.365 |
03:05 ET | 750 | 8.36 |
03:07 ET | 3790 | 8.35 |
03:09 ET | 600 | 8.34 |
03:12 ET | 2827 | 8.35 |
03:14 ET | 513 | 8.36 |
03:16 ET | 1236 | 8.36 |
03:18 ET | 2217 | 8.35 |
03:20 ET | 1000 | 8.35 |
03:21 ET | 2856 | 8.37 |
03:23 ET | 1491 | 8.37 |
03:25 ET | 900 | 8.37 |
03:27 ET | 3451 | 8.37 |
03:30 ET | 5339 | 8.345 |
03:32 ET | 5807 | 8.36 |
03:34 ET | 1006 | 8.39 |
03:36 ET | 1200 | 8.38 |
03:38 ET | 1000 | 8.385 |
03:39 ET | 2300 | 8.38 |
03:41 ET | 1660 | 8.38 |
03:43 ET | 3993 | 8.37 |
03:45 ET | 700 | 8.375 |
03:48 ET | 4695 | 8.37 |
03:50 ET | 1669 | 8.39 |
03:52 ET | 10118 | 8.395 |
03:54 ET | 7069 | 8.41 |
03:56 ET | 10768 | 8.4 |
03:57 ET | 24988 | 8.405 |
03:59 ET | 26140 | 8.43 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.2B | -2.1x | --- |
Nurix Therapeutics Inc | 1.2B | -7.7x | --- |
Prothena Corporation PLC | 1.1B | -6.2x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -3.6x | --- |
Gyre Therapeutics Inc | 1.1B | -6.5x | --- |
Immatics NV | 1.2B | -11.2x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.47 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 14.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.